Losartan Enhances the Success of Myoblast Transplantation
Duchenne muscular dystrophy is a recessive X-linked genetic disease caused by dystrophin gene mutations. Cell therapy can be a potential approach aiming to introduce a functional dystrophin in the dystrophic patient myofibers. However, this strategy produced so far limited results. Transforming grow...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2012-02-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.3727/096368911X576045 |